Global Registration Trial of Efficacy and Safety of CTL019 in Pediatric and Young Adult Patients with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL): Update to the Interim Analysis
- 1 September 2017
- journal article
- abstracts
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 17, S263-S264
- https://doi.org/10.1016/j.clml.2017.07.030